<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37038339</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1941-5923</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><PubDate><Year>2023</Year><Month>Apr</Month><Day>11</Day></PubDate></JournalIssue><Title>The American journal of case reports</Title><ISOAbbreviation>Am J Case Rep</ISOAbbreviation></Journal><ArticleTitle>A 30-Year-Old Woman with a History of Autoimmune Hyperthyroidism Presenting with Fever and Oral Ulcers, Diagnosed with Discoid Lupus Erythematosus.</ArticleTitle><Pagination><StartPage>e938988</StartPage><MedlinePgn>e938988</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.12659/AJCR.938988</ELocationID><Abstract><AbstractText>BACKGROUND Lupus erythematosus (LE) is mainly clinically divided into cutaneous lupus erythematosus (CLE) and systemic lupus erythematosus (SLE) depending on the presence of multi-system manifestations. The most common subtype of CLE is discoid lupus erythematosus (DLE). Graves' disease (GD) is immunologically characterized by lymphocytic infiltration of the thyroid gland and the presence of thyroid-stimulating hormone (TSH) receptor antibodies (TSH-R-Ab), and is the most common autoimmune pathogenic cause of hyperthyroidism. Autoimmune thyroid dysfunction has been widely described in association with rheumatic diseases. A certain rate of coexistence of GD with LE, mainly SLE, has been reported in the literature. Herein, we present a rare case of Graves' hyperthyroidism complicated with DLE. CASE REPORT A 30-year-old female patient, with a history of hyperthyroidism and discontinued methimazole treatment, initially presented with symptoms of infection and oral ulcers. Thyroid hormone, thyroid-stimulating hormone receptor antibody, and immunological tests were consistent with a diagnosis of Graves' hyperthyroidism-associated DLE. Corticosteroids and radioactive iodine (RAI) were used to treat DLE and GD, respectively. Post-treatment evaluation suggested the remission of her hyperthyroidism and active DLE. CONCLUSIONS Autoimmune thyroid diseases have been previously described in association with rheumatic diseases. This association shows the importance of prompt awareness of the increased risk of DLE when evaluating autoimmune thyroid dysfunction, especially under certain conditions, such as after treatment with anti-thyroid drugs (ATDs), or in the absence of multiple organ damage manifestations of SLE.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Yulei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Tianjin Medical University General Hospital, Tianjin, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chai</LastName><ForeName>Yanfen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Tianjin Medical University General Hospital, Tianjin, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China (mainland).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Practice, Tianjin Medical University General Hospital, Tianjin, China (mainland).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Case Rep</MedlineTA><NlmUniqueID>101489566</NlmUniqueID><ISSNLinking>1941-5923</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007457">Iodine Radioisotopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>9002-71-5</RegistryNumber><NameOfSubstance UI="D013972">Thyrotropin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019226" MajorTopicYN="Y">Oral Ulcer</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007457" MajorTopicYN="N">Iodine Radioisotopes</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013964" MajorTopicYN="Y">Thyroid Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006111" MajorTopicYN="Y">Graves Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008179" MajorTopicYN="Y">Lupus Erythematosus, Discoid</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006980" MajorTopicYN="Y">Hyperthyroidism</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013959" MajorTopicYN="Y">Thyroid Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008178" MajorTopicYN="Y">Lupus Erythematosus, Cutaneous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013972" MajorTopicYN="N">Thyrotropin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012216" MajorTopicYN="Y">Rheumatic Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of interest:</b> None declared</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37038339</ArticleId><ArticleId IdType="pmc">PMC10106092</ArticleId><ArticleId IdType="doi">10.12659/AJCR.938988</ArticleId><ArticleId IdType="pii">938988</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rasaei N, Shams M, Kamali-Sarvestani E, Nazarinia MA. The prevalence of thyroid dysfunction in patients with systemic lupus erythematosus. Iran Red Crescent Med J. 2015;17(12):e17298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4706711</ArticleId><ArticleId IdType="pubmed">26756002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahaly GJ, Bartalena L, Hegedus L, et al. 2018 European Thyroid Association guideline for the management of Graves&#x2019; hyperthyroidism. Eur Thyroid J. 2018;7(4):167&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6140607</ArticleId><ArticleId IdType="pubmed">30283735</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M, Hu Z, Mei X, et al. Single-cell sequencing shows cellular heterogeneity of cutaneous lesions in lupus erythematosus. Nat Commun. 2022;13(1):7489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9722937</ArticleId><ArticleId IdType="pubmed">36470882</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsokos GC. Autoimmunity and organ damage in systemic lupus erythematosus. Nat Immunol. 2020;21(6):605&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8135909</ArticleId><ArticleId IdType="pubmed">32367037</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">30926722</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">31383717</ArticleId></ArticleIdList></Reference><Reference><Citation>Scappaticcio L, Bellastella G, Maiorino MI, et al. Graves&#x2019; hyperthyroidism-related pancytopenia: A case report with literature review: Hormones (Athens) 2021;20(1):93&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">32638234</ArticleId></ArticleIdList></Reference><Reference><Citation>Scappaticcio L, Maiorino MI, Maio A, et al. Neutropenia in patients with hyperthyroidism: Systematic review and meta-analysis. Clin Endocrinol (Oxf) 2021;94(3):473&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">32799342</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal N, Tee SA, Saqib W, et al. Treatment of hyperthyroidism with antithyroid drugs corrects mild neutropenia in Graves&#x2019; disease. Clin Endocrinol (Oxf) 2016;85(6):949&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">27291145</ArticleId></ArticleIdList></Reference><Reference><Citation>Haber JS, Merola JF, Werth VP. Classifying discoid lupus erythematosus: Background, gaps, and difficulties. Int J Womens Dermatol. 2016;2(1):8&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5412115</ArticleId><ArticleId IdType="pubmed">28491994</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer A, Guffroy A, Blaison G, et al. Systemic lupus erythematosus and neutropaenia: A hallmark of haematological manifestations. Lupus Sci Med. 2020;7(1):e000399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7333801</ArticleId><ArticleId IdType="pubmed">32616563</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari SM, Elia G, Virili C, et al. Systemic lupus erythematosus and thyroid autoimmunity. Front Endocrinol (Lausanne) 2017;8:138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5474463</ArticleId><ArticleId IdType="pubmed">28674523</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin WY, Chang CL, Fu LS, et al. Systemic lupus erythematosus and thyroid disease: A 10-year study. J Microbiol Immunol Infect. 2015;48(6):676&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">24874431</ArticleId></ArticleIdList></Reference><Reference><Citation>Posselt RT, Coelho VN, Skare TL. Hashimoto thyroiditis, anti-thyroid antibodies and systemic lupus erythematosus. Int J Rheum Dis. 2018;21(1):186&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">28544477</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozovoy MA, Simao AN, Panis C, et al. Oxidative stress is associated with liver damage, inflammatory status, and corticosteroid therapy in patients with systemic lupus erythematosus. Lupus. 2011;20(12):1250&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">21813592</ArticleId></ArticleIdList></Reference><Reference><Citation>Agan V, Celik H, Eren MA, et al. An investigation of oxidative stress and thiol/disulphide homeostasis in Graves&#x2019; disease. Medicina (Kaunas) 2019;55(6):275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6630526</ArticleId><ArticleId IdType="pubmed">31207925</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C, Chen SF, Yang YC, et al. Association between Graves&#x2019; disease and risk of incident systemic lupus erythematosus: A nationwide populationbased cohort study. Int J Rheum Dis. 2021;24(2):240&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">33211376</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsokos GC. Autoimmunity and organ damage in systemic lupus erythematosus. Nat Immunol. 2020;21(6):605&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8135909</ArticleId><ArticleId IdType="pubmed">32367037</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli A, Ferrari SM, Corrado A, et al. Autoimmune thyroid disorders. Autoimmun Rev. 2015;14(2):174&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">25461470</ArticleId></ArticleIdList></Reference><Reference><Citation>Szyper-Kravitz M, Marai I, Shoenfeld Y. Coexistence of thyroid autoimmunity with other autoimmune diseases: Friend or foe? Additional aspects on the mosaic of autoimmunity. Autoimmunity. 2005;38(3):247&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">16126513</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato-Matsumura KC, Koizumi H, Matsumura T, et al. Lupus erythematosus-like syndrome induced by thiamazole and propylthiouracil. J Dermatol. 1994;21(7):501&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">8089372</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>